Acadia Pharmaceuticals Inc. (ACAD)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
10-Jan-22 6:23 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-22Market Option Sale 1,937$23.05$44,647.80(4%)
46.96K to 45.02K
10-Jan-22 6:22 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-22Option Exercise 9,527----18%
52.91K to 62.43K
10-Jan-22 6:25 PM
View: 
Teehan Brendan
EVP, COO, Head of Commercial
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-22Option Exercise 1,286----124%
1.04K to 2.33K
10-Jan-22 6:24 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-22Option Exercise 1,633----13%
12.14K to 13.77K
10-Jan-22 6:22 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-22Market Option Sale 3,718$23.05$85,699.90(6%)
62.43K to 58.72K
10-Jan-22 6:25 PM
View: 
Teehan Brendan
EVP, COO, Head of Commercial
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-22Market Option Sale 538$23.05$12,400.90(23%)
2.33K to 1.79K
10-Jan-22 6:24 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-22Market Option Sale 574$23.05$13,230.70(4%)
13.77K to 13.2K
10-Jan-22 6:23 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-22Option Exercise 5,444----13%
41.51K to 46.96K
23-Nov-21 6:00 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 22-Nov-21Market Option Sale 2,803$19.01$53,285.00(6%)
44.31K to 41.51K
23-Nov-21 6:00 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 19-Nov-21Option Exercise 6,250----16%
38.06K to 44.31K
19-Oct-21 5:30 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 18-Oct-21Market Option Sale 2,963$17.41$51,585.80(5%)
55.87K to 52.91K
19-Oct-21 5:31 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 18-Oct-21Market Option Sale 1,338$17.41$23,294.60(3%)
39.4K to 38.06K
19-Oct-21 5:31 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 15-Oct-21Option Exercise 2,969----8%
36.43K to 39.4K
19-Oct-21 5:30 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 15-Oct-21Option Exercise 5,938----12%
49.93K to 55.87K
01-Oct-21 5:33 PM
View: 
Garofalo Elizabeth A.
Director
Acadia Pharmaceuticals Inc. (ACAD) 29-Sep-21Option Exercise 1,918----100%
0 to 1.92K
24-Jun-21 4:22 PM
View: 
Baker Bros Advisors LLC
Director
10% Owner
Acadia Pharmaceuticals Inc. (ACAD) 22-Jun-21Grant 25,564----< 1%
42.02M to 42.05M
30-Apr-21 6:52 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 30-Apr-21Market Option Sale 7,850$20.33$159,590.00(14%)
57.16K to 49.31K
30-Apr-21 6:55 PM
View: 
Ridloff Elena
EVP and CFO
Acadia Pharmaceuticals Inc. (ACAD) 30-Apr-21Market Option Sale 1,032$20.33$20,980.60(9%)
11.59K to 10.55K
30-Apr-21 6:54 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 30-Apr-21Market Option Sale 1,054$20.33$21,427.80(8%)
12.43K to 11.37K
30-Apr-21 6:53 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 30-Apr-21Market Option Sale 4,230$20.33$85,995.90(10%)
40.66K to 36.43K
30-Apr-21 6:55 PM
View: 
Ridloff Elena
EVP and CFO
Acadia Pharmaceuticals Inc. (ACAD) 29-Apr-21Option Exercise 3,245----39%
8.34K to 11.59K
30-Apr-21 6:54 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 29-Apr-21Option Exercise 3,005----32%
9.42K to 12.43K
30-Apr-21 6:53 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 29-Apr-21Option Exercise 9,615----31%
31.05K to 40.66K
30-Apr-21 6:52 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 29-Apr-21Option Exercise 15,625----38%
41.54K to 57.16K
08-Feb-21 9:00 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Grant 31,250----264%
11.85K to 43.09K
08-Feb-21 9:00 PM
View: 
Ridloff Elena
EVP and CFO
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Market Sale 2,051$50.61$103,801.00(20%)
10.39K to 8.34K
08-Feb-21 9:00 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Market Sale 2,107$50.61$106,635.00(18%)
12.02K to 9.91K
08-Feb-21 9:00 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Market Sale 8,429$50.61$426,592.00(21%)
39.48K to 31.05K
08-Feb-21 9:00 PM
View: 
Ridloff Elena
EVP and CFO
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Grant 6,490----166%
3.9K to 10.39K
08-Feb-21 9:00 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Market Sale 14,195$50.61$718,409.00(33%)
43.09K to 28.9K
08-Feb-21 9:00 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Grant 6,009----100%
6.01K to 12.02K
08-Feb-21 9:00 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Grant 19,231----95%
20.25K to 39.48K
14-Jan-21 7:03 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 12-Jan-21Option Exercise 700$18.12$12,684.003%
20.25K to 20.95K
14-Jan-21 7:03 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 12-Jan-21Market Option Sale (Planned) 700$55.01$38,507.00(3%)
20.95K to 20.25K
08-Jan-21 7:28 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 08-Jan-21Option Exercise 29,733$27.44$815,988.00147%
20.25K to 49.98K
08-Jan-21 7:28 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 08-Jan-21Market Option Sale (Planned) 29,733$55.22$1,641,830.00(59%)
49.98K to 20.25K
08-Jan-21 7:28 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 07-Jan-21Option Exercise 61,619$35.80$2,205,960.00304%
20.25K to 81.87K
08-Jan-21 7:28 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 07-Jan-21Market Option Sale (Planned) 61,619$55.12$3,396,190.00(75%)
81.87K to 20.25K
08-Jan-21 7:28 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Option Exercise 9,527----52%
18.44K to 27.97K
08-Jan-21 7:31 PM
View: 
Yang Michael J.
EVP AND CCO
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Market Option Sale 1,120$53.34$59,740.80(12%)
9.18K to 8.06K
08-Jan-21 7:29 PM
View: 
Ridloff Elena
EVP and CFO
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Option Exercise 2,722----124%
2.19K to 4.92K
08-Jan-21 7:28 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Option Exercise 5,444----33%
16.53K to 21.97K
08-Jan-21 7:29 PM
View: 
Ridloff Elena
EVP and CFO
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Market Option Sale 1,016$53.34$54,193.40(21%)
4.92K to 3.9K
08-Jan-21 7:30 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Option Exercise 1,633----36%
4.56K to 6.2K
08-Jan-21 7:28 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Market Option Sale 1,725$53.34$92,011.50(8%)
21.97K to 20.25K
08-Jan-21 7:30 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Market Option Sale 678$53.34$36,164.50(11%)
6.2K to 5.52K
08-Jan-21 7:28 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Market Option Sale 3,484$53.34$185,837.00(12%)
27.97K to 24.48K
08-Jan-21 7:31 PM
View: 
Yang Michael J.
EVP AND CCO
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Option Exercise 2,722----42%
6.46K to 9.18K
20-Nov-20 9:29 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 20-Nov-20Market Option Sale 2,728$53.50$145,948.00(14%)
19.26K to 16.53K
20-Nov-20 9:29 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 19-Nov-20Option Exercise 6,250----48%
13.01K to 19.26K